Effectiveness of two different doses of rituximab for the treatment of rheumatoid arthritis in an international cohort: data from the CERERRA collaboration

被引：0
|
作者：
Katerina Chatzidionysiou
Elisabeth Lie
Evgeny Nasonov
Galina Lukina
Merete Lund Hetland
Ulrik Tarp
Ioan Ancuta
Karel Pavelka
Dan C. Nordström
Cem Gabay
Helene Canhão
Matija Tomsic
Piet L. C. M. van Riel
Juan Gomez-Reino
Tore K. Kvien
Ronald F. van Vollenhoven
机构：
[1] Karolinska Universitetssjukhustet,Department of Medicine, Karolinska Institute, Unit for Clinical Research Therapy, Inflammatory Diseases (ClinTrid), D1:00
[2] Diakonhjemmet Hospital,Department of Rheumatology
[3] ARBITER,DANBIO, Department of Rheumatology
[4] Institute of Rheumatology,Department of Rheumatology
[5] Copenhagen University Hospital at Glostrup,undefined
[6] Aarhus University Hospital,undefined
[7] Cantacuzino Hospital,undefined
[8] Charles University,undefined
[9] ROB-FIN Helsinki University Central Hospital,undefined
[10] SCQM registry,undefined
[11] University Hospital of Geneva,undefined
[12] Rheumatic Diseases Portuguese Register,undefined
[13] Rheumatology Research Unit,undefined
[14] Instituto de Medicina Molecular,undefined
[15] University Medical Center,undefined
[16] Radboud University Nijmegen Medical Centre,undefined
[17] Hospital Clinico Universitet De Santiago,undefined
来源：
Arthritis Research & Therapy | / 18卷
关键词：
Rituximab; Rheumatoid arthritis; Observational;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Comparative Effectiveness of Rituximab in Combination with Either Methotrexate or Leflunomide in the Treatment of Rheumatoid Arthritis
    Narvaez, Javier
    Diaz-Torne, Cesar
    Miguel Ruiz, Jose
    Victoria Hernandez, Maria
    Torrente-Segarra, Vicens
    Ros, Sergio
    Rodriguez de la Serna, Arturo
    Diaz-Lopez, Cesar
    Sanmarti, Raimon
    Miguel Nolla, Joan
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2011, 41 (03) : 401 - 405
  • [32] Rituximab in rheumatoid arthritis and the risk of malignancies: Report from a French cohort
    Slimani, Samy
    Lukas, Cedric
    Combe, Bernard
    Morel, Jacques
    JOINT BONE SPINE, 2011, 78 (05) : 484 - 487
  • [33] Cost-effectiveness treatment with Rituximab in patients with rheumatoid arthritis in real life
    Benucci, Maurizio
    Saviola, Gianantonio
    Baiardi, Paola
    Manfredi, Mariangela
    RHEUMATOLOGY INTERNATIONAL, 2011, 31 (11) : 1465 - 1469
  • [34] SURVIVAL AND EFFECTIVENESS OF RITUXIMAB TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS IN DAILY CLINICAL PRACTICE
    Gomez-Puerta, J. A.
    Uribe Botero, L.
    Urrego, J.
    Gonzalez, L. A.
    Ceron, C.
    Ochoa, C.
    Saldarriaga, M. A.
    Uribe Toro, A.
    Felipe Diaz, O. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1023 - 1024
  • [35] SMOKING AND RESPONSE TO RITUXIMAB IN ANTI-CCP POSITIVE AND NEGATIVE RHEUMATOID ARTHRITIS - RESULTS FROM AN INTERNATIONAL EUROPEAN COLLABORATION
    Chatzidionysiou, K.
    Lie, E.
    Nasonov, E.
    Lukina, G.
    Hetland, M. L.
    Hauge, E.
    Pavelka, K.
    Gabay, C.
    Nordstrom, D.
    Canhao, H.
    Tomsic, M.
    van Riel, P.
    Gomez-Reino, J.
    Ancuta, I.
    Kvien, T.
    van Vollenhoven, R.
    Saevarsdottir, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 484 - 485
  • [36] Smoking and response to rituximab in anti-CCP positive and negative rheumatoid arthritis: results from an International European Collaboration
    Chatzidionysiou, K.
    Lie, E.
    Lukina, G.
    Hetland, M.
    Hauge, E.
    Pavelka, K.
    Gabay, C.
    Nordstrom, D.
    Canhao, H.
    Tomsic, M.
    Gomez-Reino, J.
    Ancuta, I.
    Kvien, T.
    van Vollenhoven, R.
    Saevarsdottir, S.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2016, 45 : 15 - 16
  • [37] Rituximab done: what's next in rheumatoid arthritis? A European observational longitudinal study assessing the effectiveness of biologics after rituximab treatment in rheumatoid arthritis
    Walker, Ulrich A.
    Jaeger, Veronika K.
    Chatzidionysiou, Katerina
    Hetland, Merete L.
    Hauge, Ellen-Margrethe
    Pavelka, Karel
    Nordstrom, Dan C.
    Canhao, Helena
    Tomsic, Matija
    van Vollenhoven, Ronald
    Gabay, Cem
    RHEUMATOLOGY, 2016, 55 (02) : 230 - 236
  • [38] RITUXIMAB DONE! WHAT'S NEXT IN RHEUMATOID ARTHRITIS? A EUROPEAN OBSERVATIONAL LONGITUDINAL STUDY ASSESSING THE EFFECTIVENESS OF BIOLOGICS AFTER RITUXIMAB TREATMENT IN RHEUMATOID ARTHRITIS
    Walker, U. A.
    Jaeger, V. K.
    Chatzidionysiou, K.
    Hetland, M. L.
    Hauge, E. -M.
    Pavelka, K.
    Nordstrom, D. C.
    Canhao, H.
    Tomsic, M.
    van Vollenhoven, R.
    Gabay, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 492 - 492
  • [39] Cost-Effectiveness Analysis of Two Rituximab Retreatment Regimens for Longstanding Rheumatoid Arthritis
    Quartuccio, Luca
    di Bidino, Rossella
    Ruggeri, Matteo
    Schiavon, Franco
    Biasi, Domenico
    Adami, Silvano
    Punzi, Leonardo
    Cicchetti, Americo
    de Vita, Salvatore
    ARTHRITIS CARE & RESEARCH, 2015, 67 (07) : 947 - 955
  • [40] IS THERE A DIFFERENCE IN THE EFFECTIVENESS IN THE TREATMENT OF RHEUMATOID ARTHRITIS WITH RITUXIMAB IN PATIENTS WITH RHEUMATOID FACTOR POSITIVE AND NEGATIVE? A SYSTEMATIC REVIEW
    Ortiz, A. M.
    Rosario Lozano, M. P.
    Martinez Fernandez, C.
    Gonzalez-Alvaro, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 492 - 492
12345